Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016893
Filing Date
2022-11-08
Accepted
2022-11-08 16:31:48
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q albo-20220930x10q.htm   iXBRL 10-Q 1809323
2 EX-10.1 albo-20220930xex10d1.htm EX-10.1 641453
3 EX-31.1 albo-20220930xex31d1.htm EX-31.1 10378
4 EX-31.2 albo-20220930xex31d2.htm EX-31.2 10343
5 EX-32.1 albo-20220930xex32d1.htm EX-32.1 10548
  Complete submission text file 0001558370-22-016893.txt   6469171

Data Files

Seq Description Document Type Size
6 EX-101.SCH albo-20220930.xsd EX-101.SCH 41855
7 EX-101.CAL albo-20220930_cal.xml EX-101.CAL 40955
8 EX-101.DEF albo-20220930_def.xml EX-101.DEF 159509
9 EX-101.LAB albo-20220930_lab.xml EX-101.LAB 350680
10 EX-101.PRE albo-20220930_pre.xml EX-101.PRE 262654
52 EXTRACTED XBRL INSTANCE DOCUMENT albo-20220930x10q_htm.xml XML 765320
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 221369400
SIC: 2834 Pharmaceutical Preparations